ACCESSION: MSBNK-SMB_Measured-HSA015P0114018
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 23
COMMENT: RAW_SPEC {'EL22_pos_1749': {'bp': 1521679.0, 'sum': 3380834.0}, 'EL01_pos_1743': {'bp': 1329613.0, 'sum': 2857763.0}, 'EL17_pos_1731': {'bp': 1424779.0, 'sum': 3061722.0}, 'EL21_pos_1743': {'bp': 1427412.0, 'sum': 3055033.0}, 'EL19_pos_1755': {'bp': 1486203.0, 'sum': 3345122.0}, 'EL08_pos_1749': {'bp': 1358967.0, 'sum': 3110082.0}, 'EL18_pos_1743': {'bp': 1292757.0, 'sum': 2823056.0}, 'EL06_pos_975': {'bp': 1514890.0, 'sum': 4146042.0}, 'EL05_pos_963': {'bp': 1470540.0, 'sum': 4164212.0}, 'EL16_pos_957': {'bp': 1337784.0, 'sum': 3837786.0}, 'EL15_pos_1743': {'bp': 1428449.0, 'sum': 2986268.0}, 'EL18_pos_975': {'bp': 1383685.0, 'sum': 4064356.0}, 'EL14_pos_969': {'bp': 1314231.0, 'sum': 3670495.0}, 'EL19_pos_987': {'bp': 1489123.0, 'sum': 4172352.0}, 'EL23_pos_969': {'bp': 1275868.0, 'sum': 3609986.0}, 'EL24_pos_969': {'bp': 1386035.0, 'sum': 3598491.0}, 'EL20_pos_957': {'bp': 1342864.0, 'sum': 3782670.0}, 'EL21_pos_969': {'bp': 1431153.0, 'sum': 3880219.0}, 'EL04_pos_969': {'bp': 1221484.0, 'sum': 3505562.0}, 'EL22_pos_981': {'bp': 1485612.0, 'sum': 4006234.0}, 'EL08_pos_958': {'bp': 1403211.0, 'sum': 3889696.0}, 'EL15_pos_975': {'bp': 1393897.0, 'sum': 3709672.0}, 'EL07_pos_981': {'bp': 1384097.0, 'sum': 3792620.0}}
COMMENT: RETENTION_TIME_STDEV 0.595
COMMENT: PRECURSOR_M/Z_RAW 114.091704
COMMENT: PRECURSOR_M/Z_STDEV 0.000052
COMMENT: PRECURSOR_IN_MS1 mz 114.091289; int 37.920; delta(ppm) 0.668428
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.442; C6H11NO; [M+H]+; delta(ppm) -0.442149
COMMENT: PROPOSED_MF MS-FINDER 3.295; C6H11NO; [M+H]+; delta(ppm) -0.441858
COMMENT: PROPOSED_MF SIRIUS5_Sirius 23.093; C6H11NO; [M+H]+; delta(ppm) -0.441858
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) -0.441858
COMMENT: PROPOSED_MF SIRIUS6_Sirius 31.262; C6H11NO; [M+H]+; delta(ppm) -0.441858
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.669; C4H9N4; [M+H]+; delta(ppm) 11.326597
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) -0.441858
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.030; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; CC1(CC=CN1O)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.969; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; C(CCC#N)CCO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.967; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; ON=C1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.908; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; C\C=C(/C)CC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.882; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; CC(=O)C1CCCN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.502; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.270; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.245; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.245; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.168; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.152; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.147; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.115; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.114; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.112; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.091; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.061; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.060; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.060; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.060; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.060; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.043; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.032; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.031; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.009; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.990; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.967; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.967; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.949; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.910; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.858; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.991; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.778; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.776; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.769; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.735; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.679; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.673; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.623; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.568; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.561; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.561; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.558; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.558; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.502; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.410; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.389; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.352; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.335; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.278; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.278; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.275; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.075; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.834; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; azepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.040; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.649; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.619; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; N-cyclohexylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.309; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.170; XRLDSWLMHUQECH-UHFFFAOYSA-N; [M+H]+; cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; UXKZFJDNFBNQHE-RITPCOANSA-N; [M+H]+; [(1S,4R)-4-aminocyclopent-2-en-1-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.106; NWIIFKYGKOLKML-UHFFFAOYSA-N; [M+H]+; (1-aminocyclopent-3-en-1-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.103; WYQKKRBHVXDDTB-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)bicyclo[1.1.1]pentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; UHSSZVLSEAEFTI-UHFFFAOYSA-N; [M+H]+; (3-amino-1-bicyclo[1.1.1]pentanyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; JUUPISMKQGJUEL-UHFFFAOYSA-N; [M+H]+; 1-aminohex-5-yn-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; BWKHTRYJANAUCO-UHFFFAOYSA-N; [M+H]+; 2-aminospiro[2.3]hexan-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; YBZQRYWKYBZZNT-BYPYZUCNSA-N; [M+H]+; (1R)-2,2-dimethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; JXSAWOLLGHOTJJ-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.068; BOTJOIYABJNMEW-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.046; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; AAQLNWLDUWCQOD-LURJTMIESA-N; [M+H]+; (2S)-2-aminohex-5-yn-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.043; YGYOQZPGFXHQMW-XEAPYIEGSA-N; [M+H]+; [(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.043; SEHVUORORNIEOB-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.0]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.040; NZCBOEIGQAQLCD-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[4.1.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.040; QQIZPINZVQELRS-UHFFFAOYSA-N; [M+H]+; 1-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; LMDVLNHRTIBTGT-UHFFFAOYSA-N; [M+H]+; 4-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; YXNPVBNVXFDPHF-NTSWFWBYSA-N; [M+H]+; (1S,6S)-3-azabicyclo[4.1.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; VQIILGJJJQKLPC-PBXRRBTRSA-N; [M+H]+; (1R,5R,6S)-2-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; BHIQRZLQBMERJY-UHFFFAOYSA-N; [M+H]+; 5-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; VOABPFRENHXUQX-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; XFBQQBXIYXFYKY-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; OOMIMZFFLZQKIU-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; LSSWTAXATYJJOT-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; XSGGQEPWEZULLB-WDSKDSINSA-N; [M+H]+; (1R,5S)-3-azabicyclo[3.2.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; SFEYJTLKTWQWMB-HSUXUTPPSA-N; [M+H]+; [(1R,2S,5S)-3-azabicyclo[3.1.0]hexan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; IXXBUEAWNGTYSS-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; TWQMJAQGXUVGOA-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; RJFSZMRLRWNKCP-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[3.1.1]heptan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; BKHTZJDZHRFTEW-UHFFFAOYSA-N; [M+H]+; 1,2,3,6-tetrahydropyridin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; OTCYOBLTAQTFPW-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; QWJRZIUNOYNJIQ-UHFFFAOYSA-N; [M+H]+; 2-ethyl-2-hydroxybutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; KMLPEYHLAKSCGX-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; AFLIGFFKSOPBNA-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; SSZMVNBVJGCVFK-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.931; OUFBLTGDJDQVTA-UHFFFAOYSA-N; [M+H]+; 2-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; YFSGRMONVCFYTC-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-2,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; MNJYWTHQNUBTIC-RITPCOANSA-N; [M+H]+; (2S,3R)-2-ethenyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; AWZIRBSKQVRHQS-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.1.0]hexan-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; JNABLKYNVDCEJC-UHFFFAOYSA-N; [M+H]+; 1-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; QTSOGHFBXHIBFM-HCWXCVPCSA-N; [M+H]+; (1R,5S,6S)-2-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; ILYYOUOYMCOHSN-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; SZEYBIHWBKIRJG-UHFFFAOYSA-N; [M+H]+; 4-oxaspiro[2.4]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; WHCQIGAGLHHFPZ-JKUQZMGJSA-N; [M+H]+; (1S,4S,6R)-2-oxabicyclo[2.2.1]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; JPXSWTRRFQUJTC-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; ZFDMYXRXSBKBLF-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[3.1.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.896; XPMMAKUHNMSONL-UHFFFAOYSA-N; [M+H]+; 6-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; DVOBWGYOTJOCAJ-UHFFFAOYSA-N; [M+H]+; 3,4-dihydro-2H-pyran-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; GMXKRJFFSCDIAQ-UHFFFAOYSA-N; [M+H]+; 1-[1-(aminomethyl)cyclopropyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; YJOCNEVFWOGVQR-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.2.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; HEOZZUBPQNUUPG-HSUXUTPPSA-N; [M+H]+; (1R,6R,7R)-2-oxabicyclo[4.1.0]heptan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; QOQPLUHKCHMZSQ-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; GTYBCXLDMBKOHV-NTSWFWBYSA-N; [M+H]+; (1R,6S)-3-oxabicyclo[4.1.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; NVHRHGWRVNFFIB-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; PNBUAUKWRXPJFK-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.881; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.880; YOQFMSBXAJNJJA-UHFFFAOYSA-N; [M+H]+; 1-amino-3-cyclopropylpropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.880; HZAPWKALBWQUQD-UHFFFAOYSA-N; [M+H]+; 2-amino-1-cyclobutylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.880; AHVAATWZOGWTOX-UHFFFAOYSA-N; [M+H]+; 1-methyl-2-oxabicyclo[2.1.1]hexan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; PHGAOXNFCZKFTR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; IYZVTTRRGCJXGK-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; ZRBMHTFPJMSUDJ-UHFFFAOYSA-N; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; HGVPKAGCVCGRDQ-UHFFFAOYSA-N; [M+H]+; 4,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; PTSGHGGLRADEFP-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; NSRPFJGOCZUUHE-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; ZBCUGJNJBOSHIA-UHFFFAOYSA-N; [M+H]+; 4-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; IAXUBUNOIDLOLR-UHFFFAOYSA-N; [M+H]+; 3,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.855; POOPWPIOIMBTOH-UHFFFAOYSA-N; [M+H]+; 8-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.837; BCNBMSZKALBQEF-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; QMXPTUUFGSTIKK-UHFFFAOYSA-N; [M+H]+; 5-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; QPJCYJIZFCJYIR-UHFFFAOYSA-N; [M+H]+; 4-propylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; XBZJFFHSLIVHCZ-NGJCXOISSA-N; [M+H]+; (1S,2R,4R)-7-azabicyclo[2.2.1]heptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; DOTBWZRLSYDMSC-LURJTMIESA-N; [M+H]+; (2S)-2-hydroxy-2-methylpentanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; VKIGAWAEXPTIOL-LURJTMIESA-N; [M+H]+; (2S)-2-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; UWJKJTAFQCZBLA-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-2,2-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; QRWZCJXEAOZAAW-UHFFFAOYSA-N; [M+H]+; N,N,2-trimethylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.769; UUTGCNVYKLQLRV-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.764; XKDPBYCPNJRCSM-UHFFFAOYSA-N; [M+H]+; 3,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; URLVRPKEOGBFHJ-UHFFFAOYSA-N; [M+H]+; 4,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; UMECPVGLNIYFEO-UHFFFAOYSA-N; [M+H]+; 4-propan-2-ylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; LNDYIZFLFMYMEO-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-2,2-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; GFNKFZXGNLHVMK-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-4-methylpentanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; FILVIKOEJGORQS-UHFFFAOYSA-N; [M+H]+; 1,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.707; ZHAIMJRKJKQNQI-UHFFFAOYSA-N; [M+H]+; 2-oxa-7-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.703; HQQVXVKQOPZRBJ-UHFFFAOYSA-N; [M+H]+; 3,3a,4,5,6,6a-hexahydro-1H-furo[3,4-c]pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.702; MNILDQSRDHCFJG-UHFFFAOYSA-N; [M+H]+; 3-oxa-8-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; GMHPWGYTSXHHPI-UHFFFAOYSA-N; [M+H]+; azepan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.698; SGNDFJVXTXKBGO-PHDIDXHHSA-N; [M+H]+; (1S,6R)-8-oxa-3-azabicyclo[4.2.0]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.696; QJIFFAMGOQBKPK-UHFFFAOYSA-N; [M+H]+; 6-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.696; DZOONCSMZVPSHJ-UHFFFAOYSA-N; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.696; KTWRIXHINMYODR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -53.219; JBKVHLHDHHXQEQ; [M+H]+; Extrom 6m
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -84.232; PHGAOXNFCZKFTR; [M+H]+; 3-Methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -93.584; XRLDSWLMHUQECH; [M+H]+; Cyclopentancarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.059; ZRBMHTFPJMSUDJ; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.907; VRVUKQWNRPNACD; [M+H]+; pentylisocyanate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.736; XHLCYFVJQKWNRH; [M+H]+; Piperidine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -116.390; XPMMAKUHNMSONL; [M+H]+; zlchem 1132
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.605; QPJCYJIZFCJYIR; [M+H]+; beta-Caprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.286; FYCFJMPASVKULQ; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.401; GGYVTHJIUNGKFZ; [M+H]+; N-methylpiperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.108; VEZUQRBDRNJBJY; [M+H]+; Antioxidant D
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.721; ZFPGARUNNKGOBB; [M+H]+; N-Ethylpyrrolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.169; UXKZFJDNFBNQHE; [M+H]+; ((1s,4r)-4-aminocyclopent-2-enyl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.576; UFWIDNCIQKQRIJ; [M+H]+; Butyrylethylenimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.598; HOSRHDUJWMTWRD; [M+H]+; Pentane, 2-isocyanato-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.913; FEWLNYSYJNLUOO; [M+H]+; Formylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.014; SIKTVUHUQZNEPY; [M+H]+; 1-Methyl-3-piperidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.393; YGYOQZPGFXHQMW; [M+H]+; azabicyclohexanylmethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.164; HUUPVABNAQUEJW; [M+H]+; zlchem 508
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.486; YBZQRYWKYBZZNT; [M+H]+; ACMC-20dplt
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.370; USXSCBCCYNVIPN; [M+H]+; (3-Bromo-phenyl)-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.730; WDFKEEALECCKTJ; [M+H]+; N-propyl-2-propenamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.341; YNTUHDRALXNDEQ; [M+H]+; o-Methylvalerolactim
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.470; GXCJLVVUIVSLOQ; [M+H]+; 2-Propyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.886; KUQSQOIIMSDGFF; [M+H]+; Hexahydro-furo[2,3-c]pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.446; BCNBMSZKALBQEF; [M+H]+; Pyrrolidinone, dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.147; RBCSSAWYWYRREH; [M+H]+; 3-propoxypropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.301; GORGQKRVQGXVEB; [M+H]+; N-Ethyl-N-vinylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.551; HGVPKAGCVCGRDQ; [M+H]+; 4,4-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.888; UHSSZVLSEAEFTI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.003; ZCYVBYQBOWLNBU; [M+H]+; 1-(2-Methyl-1-oxopropyl)aziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.151; ZHAIMJRKJKQNQI; [M+H]+; 2-oxa-6-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.181; FDCJCIRHYZNLDV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.570; DVOBWGYOTJOCAJ; [M+H]+; 2H-Pyran, 3,4-dihydro-2-aminomethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.206; DVQLGAFYVKJEDE; [M+H]+; NN-Dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.395; BMSYXLRQGIFLFO; [M+H]+; 3-Isopropoxypropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.142; UWJKJTAFQCZBLA; [M+H]+; Butanenitrile, 4-hydroxy-2,2-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.757; FILVIKOEJGORQS; [M+H]+; 1,5-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.403; QWJRZIUNOYNJIQ; [M+H]+; 3-Pentanone cyanohydrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.324; VCUVETGKTILCLC; [M+H]+; Lopac-D-5766
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.932; IVKKELNYLUICGF; [M+H]+; 1-hydroxy-2,2-dimethyl-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.514; QCKRFEBWZBKGTR; [M+H]+; 2-hydroxy-2,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.283; QNILTEGFHQSKFF; [M+H]+; Nipam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.768; DZOONCSMZVPSHJ; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.325; TWQMJAQGXUVGOA; [M+H]+; 2-Azabicyclo[2.1.1]hexane-1-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -217.990; FVEZUCIZWRDMSJ; [M+H]+; 2-Isopropyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.019; SAOOLIIHRNLCBT; [M+H]+; ACMC-20maot
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.916; RHDNNKQDLVQQLJ; [M+H]+; 1-(propan-2-yl)aziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.387; CEMLHCYKDRPMSS; [M+H]+; Methoxypivalonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.780; YFSGRMONVCFYTC; [M+H]+; ACMC-20aoff
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.387; LJJFNFYPZOHRHM; [M+H]+; Sestamibi
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.614; WXYJAPNVTUNRQN; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.976; QZSYZIDYWNAACS; [M+H]+; 4-ethyl-2,3-dihydro-1,4-oxazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.294; AOCHNXXMYIQWEH; [M+H]+; Oxazole, 4,5-dihydro-2,4,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.886; HZRZMHNRCSIQFT; [M+H]+; 2,4,4-trimethyl-5H-oxazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -255.499; FNMKFVXIVPDFBL; [M+H]+; 4-Methylaminopent-3-en-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.619; QPWSKIGAQZAJKS; [M+H]+; 4-(dimethylamino)-3-buten-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.440; MJVIZWIQHKRBPI; [M+H]+; Aethoxen
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.912; QRWZCJXEAOZAAW; [M+H]+; N,N,2-Trimethylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.965; XEXRMKMMZOZZIF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.992; JGAMOQYFDMQPRJ; [M+H]+; 3-(Dimethylamino)methacrylaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.332; GZTXSSQZAMMARW; [M+H]+; 3,4,4-trimethyl-5H-1,3-oxazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.591; JBKVHLHDHHXQEQ; [M+H]+; Extrom 6m
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -95.381; XRLDSWLMHUQECH; [M+H]+; Cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -103.689; VEZUQRBDRNJBJY; [M+H]+; N-cyclohexylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -105.694; VRVUKQWNRPNACD; [M+H]+; Pentyl isocyanate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -109.393; UHSSZVLSEAEFTI; [M+H]+; {3-Aminobicyclo[1.1.1]pentan-1-yl}methanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.382; OKBBHAGZRNKJPR; [M+H]+; 6-Hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.430; OTCYOBLTAQTFPW; [M+H]+; (4-Oxocyclohexyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.111; KTWRIXHINMYODR; [M+H]+; 3-Methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.453; JUUPISMKQGJUEL; [M+H]+; 1-Aminohex-5-yn-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.763; SIKTVUHUQZNEPY; [M+H]+; 1-Methylpiperidin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -140.292; XHLCYFVJQKWNRH; [M+H]+; Piperidine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.133; XRLDSWLMHUQECH; [M+H]+; Cyclopentanecarboxamide
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H12N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.012
MS$FOCUSED_ION: PRECURSOR_M/Z 114.091290
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-6900000000-244da83bfc4fc80ef291
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0024311 5.8365 53.003129 1.3962 1.19 0.2672 17 f{C3H1O1}/4.53ppm,p-C3H11N1
  55.0180672 13.0611 55.018775 0.9451 2.31 0.0514 23 f{C3H3O1}/4.11ppm,p-C3H9N1
  55.0545152 25.0982 55.055223 1.0535 2.90 0.1581 23 f{C4H7}/5.24ppm,p-C2H5N1O1
  67.0544111 25.7222 67.055153 0.9843 3.23 0.4802 23 f{C5H7}/2.75ppm,p-C1H5N1O1
  68.0495859 18.6761 68.050328 0.8670 2.23 0.4303 18 f{C4H6N1}/1.62ppm,p-C2H6O1
  69.0336496 30.2100 69.034393 0.6519 6.06 0.6996 23 f{C4H5O1}/2.29ppm,p-C2H7N1
  69.0700222 128.2610 69.070765 0.3764 10.45 0.4990 23 f{C5H9}/2.11ppm,p-C1H3N1O1
  70.0652345 11.7815 70.065978 1.0419 3.22 0.2708 23 f{C4H8N1}/1.55ppm,p-C2H4O1
  70.0733249 7.0584 70.074068 1.3985 1.80 0.0441 17 ?
  71.0492586 11.7124 71.050002 1.0978 2.55 0.2745 17 f{C4H7O1}/1.65ppm,p-C2H5N1
  71.0856068 10.3550 71.086350 1.3927 1.81 0.4812 23 f{C5H11}/1.13ppm,p-C1H1N1O1
  72.0808823 21.6560 72.081625 1.0682 9.24 0.1986 23 f{C4H10N1}/1.48ppm,p-C2H2O1
  72.9372328 55.7272 72.937975 0.9323 33.45 0.4832 23 ?
  73.0469277 14.6438 73.047670 1.2184 5.90 0.3202 23 ?
  74.9376422 22.6208 74.938383 1.1476 16.09 0.0782 20 ?
  79.0543004 170.8391 79.055033 0.3542 10.91 0.7233 23 f{C6H7}/0.93ppm,p-H5N1O1
  80.0576427 10.2736 80.058372 0.9993 2.68 -0.1462 23 ?
  86.0964399 16.4993 86.097146 0.8943 4.24 0.0870 23 f{C5H12N1}/0.16ppm,p-C1O1
  91.0573920 10.6340 91.058072 0.7687 3.65 0.0257 23 ?
  95.0492020 7.7810 95.049855 1.0942 1.93 0.2696 17 f{C6H7O1}/0.64ppm,p-H5N1
  96.0807816 106.8373 96.081427 0.4059 8.70 0.5267 23 f{C6H10N1}/0.06ppm,p-H2O1
  97.0648371 39.0151 97.065474 0.7418 4.08 0.2994 23 f{C6H9O1}/0.47ppm,p-H3N1
  113.0596958 22.3838 113.060195 1.0879 4.74 0.5200 22 ?
  114.0913781 999.0000 114.091869 0.2629 0.00 1.0000 23 f{C6H12N1O1}/0.33ppm,p
  115.0947590 73.1056 115.095242 0.5300 6.17 0.5642 23 ?
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  53.002431 5.84 5
  55.018067 13.06 13
  55.054515 25.10 25
  67.054411 25.72 25
  68.049586 18.68 18
  69.033650 30.21 30
  69.070022 128.26 128
  70.065235 11.78 11
  70.073325 7.06 7
  71.049259 11.71 11
  71.085607 10.36 10
  72.080882 21.66 21
  72.937233 55.73 55
  73.046928 14.64 14
  74.937642 22.62 22
  79.054300 170.84 170
  80.057643 10.27 10
  86.096440 16.50 16
  91.057392 10.63 10
  95.049202 7.78 7
  96.080782 106.84 106
  97.064837 39.02 39
  113.059696 22.38 22
  114.091378 999.00 999
  115.094759 73.11 73
//
